The Memory Lane Foundation Advisory Board brings together distinguished leaders in dementia care, neuroscience, aging, healthcare and social impact. Its members provide scientific and strategic guidance so that the Foundation's work remains evidence-based, human-centered and focused on improving the lives of people living with dementia and those who care for them.
The Board is conceived as a multi-center scientific network. It guides the Foundation's work across three pillars:
- Content development: shaping therapeutic and educational content, including the Care Partner Channel and brain health resources, so that it reflects the best of clinical knowledge and caregiving practice.
- Efficacy research: designing and supporting real-world evaluation of Memory Lane TV. The research collaboration with Brown University is the first of several planned academic clinical implementations and evaluation through an SBIR grant application, as the Foundation's model extends from state to state.
- Fundraising and partnerships: opening doors to foundations, institutions and partners who share the goal of making Memory Lane TV a free public good.
Members serve two-year renewable terms, meet twice a year, and contribute their expertise and networks in the areas where they can make the greatest difference.
About Memory Lane Foundation
The Platform
Memory Lane TV (MLTV) is an evidence-based, multi-sensory therapeutic platform using guided imagery, soundscapes, and storytelling to improve quality of life for individuals living with dementia. Developed in Portland, Maine, by Memoro Inc. under Alban Maino, it reflects over a decade of research and clinical collaboration across the U.S., Canada, and France.
The Foundation
Memory Lane Foundation is the nonprofit carrying that work forward as a public good — making MLTV's therapeutic library of more than 1,200 original films and 1,500+ hours of programming freely available to individuals, families, and care communities, regardless of ability to pay. The catalog is already shown to reduce agitation, spark memories, foster connection, and ease the burden on care partners.
The Rollout Is Already Underway
The Foundation is rolling out free access state by state, beginning with New York, in partnership with the New York State Office for the Aging (NYSOFA).
Original Films
In MLTV's therapeutic library
Hours of Programming
Ready for free distribution
NYC Benefit Evening
2026 flagship fundraising event
The October 15th, 2026 benefit evening in New York City is this year's flagship fundraising event, with the ambition of extending the same free-access model nationwide.
Role of the Advisory Board
The Memory Lane Foundation Advisory Board unites leaders from science, medicine, technology, and philanthropy to guide the Foundation through this critical fundraising and expansion phase — serving as both a think tank and an ambassador network.
Scientific Oversight
Advance and validate the evidence base behind multi-sensory approaches to managing dementia symptoms, grounded in peer-reviewed research and clinical best practice.
Strategic Partnerships
Foster collaborations with universities, healthcare systems, state aging agencies, and philanthropic organizations to help the Foundation scale state by state.
Public Awareness & Mission Stewardship
Amplify the Foundation's message to policymakers and the medical community, while ensuring free, equitable access remains the central goal as the model expands nationally.
2026–28 Advisory Board: Science, Research & Advocacy
Dr. Mony de Leon — Chair of the Memory Lane Foundation Advisory Board
Chair of our Advisory Board, is a world-renowned Alzheimer's researcher and recipient of the AAIC Lifetime Achievement Award. He founded the Center for Brain Health at NYU and, in 2019, the Brain Health Imaging Institute at Weill Cornell Medicine, and has since retired from his professorships at both institutions. A pioneer of early hippocampal atrophy and glucose-metabolism biomarkers, he has been a leader in advancing the in-vivo detection of Alzheimer's pathology, including breakthrough work on the brain's waste-removal mechanisms.
Three decades in Alzheimer's research, diagnostics, clinical development and global medical affairs. Collaborated with Dr. de Leon on imaging and biomarker research at NYU. Former VP of Medical Affairs at Life Molecular Imaging, played a pivotal role in the launch of the first immunotherapy approved to treat early Alzheimer's at Eisai, Inc. Chaired the Public-Private Scientific Board of ADNI.
Dr Susan Wehry is a nationally recognized keynote speaker and workshop facilitator on depression, dementia, and healthy aging. Her presentations combine over 30 years experience with wisdom, compassion, and common sense, to engage attendees, help build skills, and use proven techniques.
A licensed clinical psychologist with three decades in healthcare, fifteen of them in senior living, she founded the Dementia Connection Institute and created the Dementia Connection Model, a framework for non-pharmacological care taught to professional and family caregivers. She is the author of The Busy Caregiver's Guide to Advanced Alzheimer Disease (Johns Hopkins University Press).
Rosa Baier directs Brown University’s Long-Term Care Quality & Innovation research group, advancing pragmatic, real-world research to improve care for older adults. Her work combines partner engagement, implementation science, and healthcare innovation, and she holds leadership roles in major NIH-funded initiatives expanding the field’s capacity for embedded pragmatic research.
Virginie Durr — Diplomacy & Global Partnerships
Senior executive at Delta Air Lines (Chairman's Club Honoree). Awarded the French Legion of Honor; Foreign Trade Advisor for France; Board Member of the French-American Chamber of Commerce. Brings global partnership strategy, mobility leadership, and international diplomatic reach.
Led NeuroScience Associates for eighteen years. Founder of Whole in One Health and creator of AlzMeter, a brain health assessment showing individuals their own risk and actionable lifestyle factors. Driven by personal experience with dementia in her own family.
Ethelle Lord — Advocacy & Philanthropy
Founder, International Caregivers Association. Came to this work through her husband's 2003 vascular dementia diagnosis. Built a dementia coaching practice and certification for professional and family caregivers. Holds a doctorate in organizational leadership from the University of Maine and is a past president of the Maine Gerontological Society.
Legacy Advisory Board (2016–2024)
Prior advisors who contributed to MLTV's development before the Foundation's creation.
Medical & Research Leadership
- Dr. Herbert Benson — Director Emeritus, Benson-Henry Institute, Harvard Medical School (2018–19)
- Dr. Gregory Fricchione — Director, Benson-Henry Mind Body Institute, MGH (2018–19)
- Prof. William H. Frey II — Sr. Research Director, Center for Memory & Aging, University of Minnesota (2019–20)
- Dr. George Perry — Dean, University of Texas at San Antonio (2019–20)
- Dr. Angel Duncan — Art Therapist & Dementia Researcher (2020–21)
Business & Strategy
- Sophie Korknowski - Sophie Kornowski is the reason Memory Lane TV exists. A former senior leader at Roche, she later led Boston Pharmaceuticals and now advises life science companies through SophieKor Insights.
- John Conley — Director, Launchpad Venture Group (2021–22)
- Ronald Kami — General Counsel, Waypoint Capital Group (2022–24)
International Committee
- Dr. Blandine Raffin — Geriatric MD, France (2016–18)
- Geneviève Goreux Marois — President, Institute of Life, Paris (2018–23)
Join the Mission
The Advisory Board's collective goal is to ensure that Memory Lane TV becomes what it was always meant to be: a freely accessible, public resource improving the daily lives of people living with dementia and those who care for them.
Memory Lane Foundation Advisory Board